 |
인쇄하기
취소
|
Stem cells bring life to Korea’s biotech industry
Korea has steadily regained its place as a stem cell research powerhouse, relaxing regulations and producing the world’s first three commercialized stem cell treatments.
Global demand for stem cell therapies is forecast to grow to $12.5 billion in 2019 from $2.7 billion in 2009.
In July 2011, Hearticellgram-AMI, developed by Korean biotechnology firm FCB-Pharmicell, was approved by the Ko...
Global demand for stem cell therapies is forecast to grow to $12.5 billion in 2019 from $2.7 billion in 2009.
In July 2011, Hearticellgram-AMI, developed by Korean biotechnology firm FCB-Pharmicell, was approved by the Ko...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.